Literature DB >> 7461058

Synthetic erythrocytes from lipid encapsulated hemoglobin.

L Djordjevich, I F Miller.   

Abstract

Synthetic erythrocytes have been formed by encapsulating concentrated hemoglobin solutions in microcapsules consisting of phospholipid-cholesterol mixtures. The microcapsules (hemosomes) are of the order of one micron in diameter or smaller, are osmometers, are somewhat sturdier than erythrocytes (RBC), and are stable upon freezing. They have essentially the same oxygen and carbon dioxide carrying capacity as RBC, and can be tailored to have the same electrokinetic properties. They appear to evoke no immune response in the rat. In experiments involving complete replacement of natural blood hemosomes appear to sustain life. Rats can live and breathe normally without signs of hypoxia or acidosis for extended periods of time after the hematocrit of natural RBC drops well below the critical level. Synthetic erythrocytes do not appear to cause disseminated coagulation, microembolism, or any observable changes in internal organs.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7461058

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  17 in total

Review 1.  From artificial red blood cells, oxygen carriers, and oxygen therapeutics to artificial cells, nanomedicine, and beyond.

Authors:  Thomas M S Chang
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2012-03-13

2.  Nanobiotechnological modification of hemoglobin and enzymes from this laboratory.

Authors:  Thomas Ming Swi Chang
Journal:  Biochim Biophys Acta       Date:  2008-06-17

Review 3.  Blood substitutes: possibilities with nanotechnology.

Authors:  Feroz Alam; Neha Yadav; Murad Ahmad; Mariyam Shadan
Journal:  Indian J Hematol Blood Transfus       Date:  2013-12-10       Impact factor: 0.900

Review 4.  Blood transfusion: yesterday, today, and tomorrow.

Authors:  W J Rudowski
Journal:  World J Surg       Date:  1987-02       Impact factor: 3.352

5.  2017 Military Supplement: Hemoglobin-based Oxygen Carriers: Current State-of-the-Art and Novel Molecules.

Authors:  Anirban Sen Gupta
Journal:  Shock       Date:  2017-09-29       Impact factor: 3.454

6.  Oxidative interactions between haemoglobin and membrane lipid. A liposome model.

Authors:  J Szebeni; C C Winterbourn; R W Carrell
Journal:  Biochem J       Date:  1984-06-15       Impact factor: 3.857

7.  Long-term effects on the histology and function of livers and spleens in rats after 33% toploading of PEG-PLA-nano artificial red blood cells.

Authors:  Zun Chang Liu; Thomas M S Chang
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2008-12-09

8.  Novel Nanodimension artificial red blood cells that act as O2 and CO2 carrier with enhanced antioxidant activity: PLA-PEG nanoencapsulated PolySFHb-superoxide dismutase-catalase-carbonic anhydrase.

Authors:  Wei Gao; Yuzhu Bian; Thomas M S Chang
Journal:  Artif Cells Nanomed Biotechnol       Date:  2013-01-22       Impact factor: 5.678

Review 9.  Blood and plasma substitutes--plasma expansion and oxygen transport properties.

Authors:  K Waxman; K K Tremper; G R Mason
Journal:  West J Med       Date:  1985-08

10.  Effect of liposome-encapsulated hemoglobin, neo red cells, on hemorrhagic shock.

Authors:  A Usuba; F Osuka; T Kimura; R Sato; Y Ogata; H Gotoh; T Kimura; H Fukui
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.